RA

Rashmi Atray

Active Director Designated Partner DIN 10783654
DIN 10783654 First appointment Sep 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value •••• Premium profile

About Rashmi Atray

Data last updated:

Rashmi Atray is a Designated Partner at Vivotex Pharma Llp (since 2024). The company operates in Pharma. Vivotex Pharma Llp reported revenue of ₹1.65 Cr (FY 2023).

DIN 10783654
Primary Designation Designated Partner
Industry Pharma
First Appointment 30 Sep 2024
Oldest Company Age 7 yrs
Largest company Vivotex Pharma Llp · ₹1.65 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner30 Sep 20242019₹1.65 Cr (FY 2023)Active

Board colleagues of Rashmi Atray

NameDINCompanyDesignation
Ashish Singh10429598Vivotex Pharma LlpDesignated Partner
Mukarram Ahamad10783623Vivotex Pharma LlpDesignated Partner
Nar Singh10429745Vivotex Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Vivotex Pharma Llp
Premium access

Shareholding and investment profile for Rashmi Atray

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rashmi Atray

Rashmi Atray currently holds 1 directorship: Vivotex Pharma Llp (Designated Partner, since 30 Sep 2024, revenue ₹1.65 Cr (FY 2023)).

Rashmi Atray was first appointed on 30 Sep 2024 as Designated Partner at Vivotex Pharma Llp.

The current boards of Rashmi Atray's companies include Ashish Singh (Vivotex Pharma Llp), Mukarram Ahamad (Vivotex Pharma Llp), Nar Singh (Vivotex Pharma Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available